Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium tanshinone IIA plus simvastatin for inflammatory markers in coronary heart disease
ChiCTR-TRC-12002361Phase 4Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium tanshinone IIA sulfonate and simvastatin in coronary arteriosclerosis (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Serum high-sensitivity C-reactive protein level. Started Aug 2012; status: completed.
02
Drugs
sodium tanshinone IIA sulfonatesimvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002361.